Express Scripts (ESRX)

ESRX (NASDAQ:Health Services)
$66.02
neg -0.62
-0.93%
Today's Range: 65.08 - 66.23 | ESRX Avg Daily Volume: 5,325,800
Last Update: 07/23/14 - 4:00 PM EDT
Volume: 6,645,237
YTD Performance: -5.13%
Open: $66.00
Previous Close: $66.64
52 Week Range: $59.20 - $79.37
Oustanding Shares: 773,580,000
Market Cap: 51,009,865,200
6-Month Chart
TheStreet Ratings Grade for ESRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 13 13
Moderate Buy 2 2 2 2
Hold 4 5 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.53 1.61 1.50 1.50
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 28.83
Price Earnings Comparisons:
ESRX Sector Avg. S&P 500
28.83 29.80 28.87
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-6.09% -0.64% 16.30%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.90 1.31 0.32
Net Income 40.80 0.60 0.17
EPS 28.00 0.04 0.01
Earnings for ESRX:
EBITDA 6.00B
Revenue 104.10B
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $1.22 $1.28 $4.87 $5.53
Number of Analysts 14 13 16 16
High Estimate $1.24 $1.33 $4.90 $5.62
Low Estimate $1.20 $1.22 $4.80 $5.36
Prior Year $1.11 $1.08 $4.33 $4.87
Growth Rate (Year over Year) 9.85% 18.38% 12.47% 13.54%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Bret Jensen

 | Jul 18, 2014 | 10:30 AM EDT

Using the bull put spread in times of volatility.

By

Paul Price

 | Jul 17, 2014 | 10:00 AM EDT

A lower price means more value for this high-quality stock.

bullishExpress Scripts target raised at Leerink

Jun 4, 2014 | 8:11 AM EDT

ESRX target was raised to $85 from $80, Leerink Partners said. Company should benefit from a 10-year contract with WellPoint. Outperform rating. 

By

Paul Price

 | May 2, 2014 | 11:00 AM EDT

Even the best company, when overvalued, can be a bad stock.

By

Jim Cramer

 | May 1, 2014 | 3:05 PM EDT

But three days like this and valuations will shift again.

bearishExpress Scripts price target cut at Barclays

May 1, 2014 | 8:16 AM EDT

ESRX lowered its numbers, Barclays said. Driven by lingering winter weather effects and contract implementation delays. $83 price target and Overweight rating. 

By

Scott Redler

 | Mar 24, 2014 | 6:15 PM EDT

Apple gaps up on Comcast talks news triggering our $538 entry price.

By

Paul Price

 | Mar 24, 2014 | 11:00 AM EDT

Trading history indicates company officers are made right move.

By

Scott Redler

 | Mar 20, 2014 | 6:15 PM EDT

Hudson City Bankcorp looks poised to be the next breakout candidate.

By

Scott Redler

 | Mar 19, 2014 | 6:18 PM EDT

Michael Kors triggers our $99 entry price, closes on highs.

The semiconductor sector performed poorly today with the Market Vectors Semiconductor (SMH...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Bef...
ive tried to sense how these new rules can possibly be good for the mkt--and struck out tr...

Skip Raschke and I have been talking about ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.